Köpspris
25,33
25,33
25,32
233.06 B
Information om tidigare resultat är inte en tillförlitlig indikator på framtida resultat.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Skapa ett konto och gör en snabb verifiering.
Lägg till pengar i din plånbok via kort, banköverföring eller krypto.
Välj PFE, ställ in beloppet och klicka på köp eller sälj - så är det klart!
Pfizer Inc.
PFE
25,325
+0.68%
FAQ